A Reinforcement Learning Based System for Blood Glucose Control without Carbohydrate Estimation in Type 1 Diabetes: In Silico Validation

Annu Int Conf IEEE Eng Med Biol Soc. 2022 Jul:2022:950-956. doi: 10.1109/EMBC48229.2022.9871054.

Abstract

Type 1 Diabetes (T1D) is a chronic autoimmune disease, which requires the use of exogenous insulin for glucose regulation. In current hybrid closed-loop systems, meal entry is manual which adds cognitive burden to the persons living with T1D. In this study, we proposed a control system based on Proximal Policy Optimisation (PPO) that controls both basal and bolus insulin infusion and only requires meal announcement, thus eliminating the need for carbohydrate estimation. We evaluated the system on a challenging meal scenario, using an open-source simulator based on the UVA/Padova 2008 model and achieved a mean Time in Range value of 65% for the adult subject cohort, while maintaining a moderate hypoglycemic and hyperglycemic risk profile. The approach shows promise and welcomes further research towards the translation to a real-life artificial pancreas. Clinical relevance- This was an in-silico analysis towards the development of an autonomous artificial pancreas system for glucose control. The proposed system show promise in eliminating the need for estimating the carbohydrate content in meals.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Blood Glucose
  • Computer Simulation
  • Diabetes Mellitus, Type 1*
  • Glycemic Control
  • Humans
  • Insulin

Substances

  • Blood Glucose
  • Insulin